Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
29.7M
-
Shares change
-
+952K
-
Total reported value, excl. options
-
$90.1M
-
Value change
-
+$448K
-
Put/Call ratio
-
1.71
-
Number of buys
-
51
-
Number of sells
-
-21
-
Price
-
$3.03
Significant Holders of Protara Therapeutics, Inc. - Common Stock (TARA) as of Q2 2025
91 filings reported holding TARA - Protara Therapeutics, Inc. - Common Stock as of Q2 2025.
Protara Therapeutics, Inc. - Common Stock (TARA) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.7M shares
of 38.5M outstanding shares and own 77.25% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (4.1M shares), BlackRock, Inc. (2.14M shares), Velan Capital Investment Management LP (2.14M shares), Blackstone Inc. (1.91M shares), VANGUARD GROUP INC (1.8M shares), ACORN CAPITAL ADVISORS, LLC (1.75M shares), Catalio Capital Management, LP (1.63M shares), Integral Health Asset Management, LLC (1.4M shares), STEMPOINT CAPITAL LP (1.14M shares), and UBS Group AG (1.14M shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.